EIP boosts medtech practice with HGF partner
11-02-2020
Medtech company backs down from Pfizer TM oppositions
14-08-2018
metamorworks / Shutterstock.com
The role of the doctrine of equivalents in assessing the value of, and risks associated with, medtech patents is often overlooked. Christopher Bright and Nathan Smith of Morgan Lewis report.
Medtech—and its resultant impact on global healthcare—could not be more urgently needed than now. Benefiting from the convergence of medical and technological advances, medtech promises not only new medical devices, diagnostics and treatments, but also new channels for more effectively delivering healthcare, all with better outcomes.
But the promise of medtech can be realised only if there is sufficient incentive to develop medtech, which requires a clear understanding of the extent of the exclusivity and value of the medtech patent portfolio landscape.
To gain that clear understanding medtech innovators assessing the value of their patent portfolios, and medtech implementers assessing their patent infringement risk, must consider the role that the Doctrine of Equivalents (DoE) plays in assessing medtech patents in the US.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
Medtech, patent portfolio, Morgan Lewis, healthcare, innovator, DoE, US Supreme Court, medical devices, software, telecoms, technology, IoT, automotive
